{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.46","value":"1.29"},{"groupId":"OG001","spread":"0.44","value":"1.23"},{"groupId":"OG002","spread":"0.00","value":"1.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"title":"Baseline: Mobility"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.31","value":"1.11"},{"groupId":"OG001","spread":"0.28","value":"1.08"},{"groupId":"OG002","spread":"0.00","value":"1.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"title":"Baseline: Self-Care"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.65","value":"1.45"},{"groupId":"OG001","spread":"0.38","value":"1.15"},{"groupId":"OG002","spread":"0.00","value":"1.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"title":"Baseline: Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.63","value":"1.63"},{"groupId":"OG001","spread":"0.52","value":"1.54"},{"groupId":"OG002","spread":"0.29","value":"1.08"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"title":"Baseline: Pain/Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.31","value":"1.11"},{"groupId":"OG001","spread":"0.28","value":"1.08"},{"groupId":"OG002","spread":"0.00","value":"1.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"title":"Baseline: Anxiety/Depression"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.6","value":"72.8"},{"groupId":"OG001","spread":"7.7","value":"83.9"},{"groupId":"OG002","spread":"5.9","value":"87.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"title":"Baseline: Health Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.48","value":"1.34"},{"groupId":"OG001","spread":"0.49","value":"1.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"title":"Follow-Up: Mobility"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.26","value":"1.07"},{"groupId":"OG001","spread":"0.39","value":"1.17"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"title":"Follow-Up: Self-Care"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.49","value":"1.38"},{"groupId":"OG001","spread":"0.45","value":"1.25"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"title":"Follow-Up: Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.63","value":"1.59"},{"groupId":"OG001","spread":"0.51","value":"1.42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"title":"Follow-Up: Pain/Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.41","value":"1.21"},{"groupId":"OG001","spread":"0.29","value":"1.08"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"title":"Follow-Up: Anxiety/Depression"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.5","value":"75.1"},{"groupId":"OG001","spread":"15.6","value":"79.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"title":"Follow-Up: Health Score"}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"12"}],"units":"Participants"}],"description":"Secondary Objective 3: To assess how quality of life compares between groups and longitudinally in patients with myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and healthy volunteers.\n\nThe EuroQol 5-Dimension (EQ-5D) assess the mobility, self-care, usual activities, pain/discomfort, anxiety and depression on a 5-point scale, in which a lower score represents better quality of life (1 = 'no problems', 5 = maximum problems, for each domain). The second part of the EQ-5D assess health on a scale where 100 is the best health and 0 is the worst health.","dispersionType":"Standard Deviation","groups":[{"description":"Participants recruited with myeloma","id":"OG000","title":"Group 1- Myeloma"},{"description":"Participants recruited with MGUS","id":"OG001","title":"Group 2- MGUS"},{"description":"Participants recruited as healthy volunteers","id":"OG002","title":"Group 3- Healthy Volunteers"}],"paramType":"MEAN","populationDescription":"All participants from Groups 1, 2 and 3 were invited to complete EQ5D questionnaires at baseline and 6-month follow-up visits.\n\nThe total number of patients analysed for each EQ5D question varied slightly depending on how many responses were received from the questionnaires.","reportingStatus":"POSTED","timeFrame":"At baseline and six months","title":"Secondary Objective 3: Assess Participants' Quality of Life Throughout the Study","type":"SECONDARY","unitOfMeasure":"Scores on a scale"}